Stock Evaluator: Sol-Gel Technologies Ltd. (SLGL)

Sol-Gel Technologies Ltd. SLGL

$66.79 -2.39 -3.45%
September 10, 2026 4:00:00 PM EST November 10, 2021 Volume: 84,206
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Pharmaceuticals

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat olmsted syndrome. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.

Commentary & Analysis


Financial Summary

Share Statistics SLGL Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $218.7 $626.3 28%
Shares Out (Mil) 3.3 43.4 11%
Institutional Ownership 22.0% 83.9% 10%
Float (Mil) 0.5 45.7 1%
Beta 1.16 0.73 69%
Avg Daily Volume (000s) 80 309 34%
Price Change
(52-week)
157.6% 66.6% 96%
Growth SLGL Industry
Median
Percentile
(All Stocks)
Sales (5yr) 17.1% 6.7% 77%
Net Income (5yr) 26.9% (1.6%) 82%
EPS (5yr) 29.9% 15.1% 81
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (35.6%) (15.0%) 15%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 1 2 4
Current EPS ($3.010) ($9.475) ($7.703)
Month Ago EPS ($2.580) ($8.318) ($8.145)
# Rev Up 0 1 0
# Rev Down 0 0 1
Three Months Ago EPS ($3.450) ($8.263) ($10.880)
Year/Year Chg 167.3% 330.9% (2.2%)
Financials SLGL Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $2 $317 3%
Net Income (TTM) (Mil) ($16) ($11) 25%
EPS (TTM) ($5.593) ($0.700) 7%
Operating Cash Flow (TTM) (Mil) na ($6) na
Net Cash Flow (TTM) (Mil) na $6 na
Long-Term Debt (Q1) (Mil) $0 $6 13%
Enterprise Value (Q1) (Mil) $206 $525 26%
Valuation SLGL Industry
Median
Percentile
(All Stocks)
P/B 4.55 2.69 77%
P/E na 16.8 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.0 na
Ratios SLGL Industry
Median
Percentile
(All Stocks)
Gross Margin (781.3%) 68.8% 0%
Net Margin (910.1%) (1.4%) 0%
ROA (34.1%) (24.1%) 16%
ROE (39.4%) (21.4%) 18%
Liabilities to Assets 10.5% 33.1% 6%
F-Score 2 3 7%

Sol-Gel Technologies Ltd. did not pass any screens on 9/10/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors